172 related articles for article (PubMed ID: 26354343)
1. Adverse prognostic impact of bone marrow microvessel density in multiple myeloma.
Lee N; Lee H; Moon SY; Sohn JY; Hwang SM; Yoon OJ; Youn HS; Eom HS; Kong SY
Ann Lab Med; 2015 Nov; 35(6):563-9. PubMed ID: 26354343
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
Bhatti SS; Kumar L; Dinda AK; Dawar R
Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
Rajkumar SV; Mesa RA; Fonseca R; Schroeder G; Plevak MF; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Russell SJ; Greipp PR
Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422
[TBL] [Abstract][Full Text] [Related]
4. Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance.
Marković O; Marisavljević D; Cemerikić V; Vidović A; Perunicić M; Todorović M; Elezović I; Colović M
Med Oncol; 2008; 25(4):451-7. PubMed ID: 18449811
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma.
Sezer O; Niemöller K; Eucker J; Jakob C; Kaufmann O; Zavrski I; Dietel M; Possinger K
Ann Hematol; 2000 Oct; 79(10):574-7. PubMed ID: 11100749
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy.
Kumar S; Gertz MA; Dispenzieri A; Lacy MQ; Wellik LA; Fonseca R; Lust JA; Witzig TE; Kyle RA; Greipp PR; Rajkumar SV
Bone Marrow Transplant; 2004 Aug; 34(3):235-9. PubMed ID: 15170170
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myeloma.
Ribas C; Colleoni GW; Silva MR; Carregoza MJ; Bordin JO
Eur J Haematol; 2004 Nov; 73(5):311-7. PubMed ID: 15458509
[TBL] [Abstract][Full Text] [Related]
8. Relationship between bone marrow angiogenesis and plasma cell infiltration and serum beta2-microglobulin levels in patients with multiple myeloma.
Sezer O; Niemöller K; Jakob C; Zavrski I; Heider U; Eucker J; Kaufmann O; Possinger K
Ann Hematol; 2001 Oct; 80(10):598-601. PubMed ID: 11732871
[TBL] [Abstract][Full Text] [Related]
9. Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis.
Munshi NC; Wilson C
Semin Oncol; 2001 Dec; 28(6):565-9. PubMed ID: 11740810
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III.
Niemöller K; Jakob C; Heider U; Zavrski I; Eucker J; Kaufmann O; Possinger K; Sezer O
J Cancer Res Clin Oncol; 2003 Apr; 129(4):234-8. PubMed ID: 12700896
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
[TBL] [Abstract][Full Text] [Related]
12. Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines,angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcome.
Mileshkin L; Honemann D; Gambell P; Trivett M; Hayakawa Y; Smyth M; Beshay V; Ritchie D; Simmons P; Milner AD; Zeldis JB; Prince HM
Haematologica; 2007 Aug; 92(8):1075-82. PubMed ID: 17640854
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of bone marrow angiogenesis in multiple myeloma.
Rajkumar SV; Leong T; Roche PC; Fonseca R; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Kyle RA; Gertz MA; Greipp PR
Clin Cancer Res; 2000 Aug; 6(8):3111-6. PubMed ID: 10955791
[TBL] [Abstract][Full Text] [Related]
14. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia.
Smolej L; Kasparová P
APMIS; 2008 Dec; 116(12):1058-62. PubMed ID: 19133008
[TBL] [Abstract][Full Text] [Related]
15. Absence of clinical prognostic value of vascular endothelial growth factor and microvessel density in multiple myeloma.
Choi JH; Ahn MJ; Jang SJ; Park CK; Park YW; Oh HS; Lee YY; Choi IY; Kim IS
Int J Hematol; 2002 Dec; 76(5):460-4. PubMed ID: 12512841
[TBL] [Abstract][Full Text] [Related]
16. Decrease of bone marrow angiogenesis in myeloma patients achieving a remission after chemotherapy.
Sezer O; Niemöller K; Kaufmann O; Eucker J; Jakob C; Zavrski I; Possinger K
Eur J Haematol; 2001 Apr; 66(4):238-44. PubMed ID: 11380603
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of microvessel density and mast cell density for the survival of Thai patients with primary colorectal cancer.
Yodavudh S; Tangjitgamol S; Puangsa-art S
J Med Assoc Thai; 2008 May; 91(5):723-32. PubMed ID: 18672639
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agents.
Cibeira MT; Rozman M; Segarra M; Lozano E; Rosiñol L; Cid MC; Filella X; Bladé J
Cytokine; 2008 Mar; 41(3):244-53. PubMed ID: 18178097
[TBL] [Abstract][Full Text] [Related]
19. Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients.
Pruneri G; Ponzoni M; Ferreri AJ; Decarli N; Tresoldi M; Raggi F; Baldessari C; Freschi M; Baldini L; Goldaniga M; Neri A; Carboni N; Bertolini F; Viale G
Br J Haematol; 2002 Sep; 118(3):817-20. PubMed ID: 12181051
[TBL] [Abstract][Full Text] [Related]
20. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
